Grief Counseling Market Set to Reach $5.83B by 2030 Amid Digital Health Expansion

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Grief counseling market projected to grow from $3.67B to $5.83B by 2030, driven by digital health expansion and increased mental health awareness.

Grief Counseling Market Set to Reach $5.83B by 2030 Amid Digital Health Expansion

The grief counseling market is anticipated to expand significantly over the next five years, growing from $3.67 billion in 2025 to $5.83 billion by 2030, representing a compound annual growth rate of 9.7%. This expansion reflects broader shifts in how mental health services are being delivered and accessed across healthcare systems.

Several factors are catalyzing this market growth, including heightened awareness of mental health challenges, the proliferation of digital and telehealth platforms, and increased recognition of the need for accessible bereavement support services. These trends have enabled providers to extend grief counseling services beyond traditional in-person settings, reaching underserved populations and improving convenience for patients seeking support during critical periods.

The competitive landscape is anchored by established healthcare organizations including Cleveland Clinic, LifeStance Health, VITAS Healthcare, and Talkspace, which have positioned themselves at the forefront of the market by integrating technology with clinical expertise. These players are leveraging their platforms to address the growing demand for professional grief counseling services in an increasingly digital healthcare environment.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 23

Related Coverage

Investing.com

Hims & Hers Pivots to Brand-Name GLP-1s as Novo Deal Reshapes Growth Strategy

Hims & Hers reports Q1 earnings May 11 after settling patent dispute with Novo Nordisk, gaining rights to sell Wegovy and Ozempic while discontinuing compounded alternatives.

NVOHIMS
GlobeNewswire Inc.

LifeStance Health Facilitates $285M Secondary Offering as Insiders Monetize Stakes

LifeStance Health ($LFST) prices $285M secondary offering of 35M shares at $8.15 each, with company repurchasing 6M shares to offset dilution.

LFST
GlobeNewswire Inc.

LifeStance Surges on Strong Q1 Results, Raises 2026 Guidance

$LFST posts 21% YoY revenue growth to $403.5M, swings to $14.2M profit. Raises full-year guidance amid 11% clinician expansion.

LFST
The Motley Fool

Tilray's Low Valuation Masks Deeper Troubles in Booming Cannabis Beverage Market

Tilray trades cheaply in the fast-growing cannabis beverage sector, but persistent losses and weak fundamentals suggest it's a value trap, not a bargain.

TLRY
Benzinga

Mobile Health Stock Surges 21% on $119M Strategic Framework to Expand AI Healthcare

Mobile Health Network shares surge 21% after announcing $119M framework to acquire BIMA and M&M Helix, expanding AI healthcare services across Asia and Africa.

MNDR
GlobeNewswire Inc.

Stem Cell Therapy Market Surges to $58.5B by 2034 on Tech, Regulation Tailwinds

Global stem cell therapy market projected to grow from $21.9B in 2025 to $58.5B by 2034 at 11% CAGR, driven by technological advances and favorable regulations.

TAKVCELSMDPY